EUVIMEDEUVIMED entdecken
Kohortenstudie

A missed opportunity: a retrospective cohort study of alcohol use disorder pharmacotherapy in hospitalized patients

Michka Nazon, Paola Lavin iD, C William Pike, Kyle T Greenway, Jérémie Richard, Paul L'Espérance, Michael Ostacher, Didier Jutras-Aswad, Steven Tate, Anna Lembke, Nicolas Garel iD

Alcohol and Alcoholism · 2026

DOI: 10.1093/alcalc/agag008 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Alcohol and Alcoholism, 2026. Verfasst von Michka Nazon und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, 2900 boul. Edouard-Montpetit, Montréal, QC H3T1J4, Canada. Hauptthemen laut MEDLINE: Alcoholism, Alcohol Deterrents, Hospitalization. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Health Services Research Administration Stanford Addiction Medicine Fellowship program research funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Alcohol use disorder (AUD) poses a significant public health challenge. Despite the availability of effective pharmacological treatments, their use during hospitalization remains limited. This study aimed to evaluate the prevalence of medication for AUD (MAUD) during inpatient admissions and assess its association with subsequent emergency department (ED) visits and hospital readmissions. Materials and Methods We conducted a retrospective cohort study using electronic health records from Stanford Health Care (SHC) between 2015 and 2023. Hospitalized adults with a documented diagnosis of AUD (n = 7560) were categorized based on whether they received acamprosate, naltrexone, or disulfiram during admission. Outcomes included ED visits and hospital readmissions at 3- and 12-month follow-up. High-dimensional propensity score (HdPS) matching was used to control for baseline confounders.

Results

Only 3% of patients with AUD received pharmacotherapy during hospitalization. After HdPS matching, we compared 131 patients who received MAUD to 131 patients who did not. No statistically significant differences were found in ED visits within 3 months (OR = .83; 95% CI: .45, 1.51) or 12 months (OR = .66; 95% CI: .39, 1.14), nor in hospital readmissions at 3 months (OR = .87; 95% CI: .47, 1.59) or 12 months (OR = .81; 95% CI: .58, 1.12).

Conclusions

MAUD was rarely administered during hospitalization, representing a critical missed opportunity for intervention. While effect estimates favored treated patients, limited sample size precluded definitive conclusions. Efforts to improve implementation of AUD pharmacotherapy in inpatient settings are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlcoholismAlcohol DeterrentsHospitalizationHumansRetrospective StudiesFemaleMaleMiddle AgedDisulfiramPatient ReadmissionAcamprosateEmergency Room VisitsAdultNaltrexoneCohort Studies

Stichwörter der Autor:innen

alcoholalcohol use disorderpharmacotherapy

Substanzen

Alcohol DeterrentsDisulfiramAcamprosateNaltrexone

Autor:innen und Institutionen

  • Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, 2900 boul. Edouard-Montpetit, Montréal, QC H3T1J4, Canada.
  • Research Centre, Centre Hospitalier de l'Université de Montréal, 900 Saint-Denis Street, Montréal, QC H2X 0A9, Canada.
  • Atropos Health, 71 W 83rd Street #3R, New York, NY 10024, United States.
  • Department of Psychiatry, Faculty of Medicine, McGill University, 1033 Av. Des Pins, Montréal, QC H3A 1A1, Canada.
  • Lady Davis Institute, Jewish General Hospital, 3755 Chem, De la Côte-Sainte-Catherine, Montréal, QC H3T 1E2, Canada.
  • Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Baltimore, MD 21287, United States.

ORCID-Profile: Paola Lavin, Nicolas Garel

Förderung

  • Health Services Research Administration Stanford Addiction Medicine Fellowship program research funds

Zitieren

APA

Nazon, M., Lavin, P., Pike, C. W., Greenway, K. T., Richard, J., L'Espérance, P., Ostacher, M., Jutras-Aswad, D., Tate, S., Lembke, A., & Garel, N. (2026). A missed opportunity: a retrospective cohort study of alcohol use disorder pharmacotherapy in hospitalized patients. Alcohol and Alcoholism. https://doi.org/10.1093/alcalc/agag008

Vancouver

Nazon M, Lavin P, Pike CW, Greenway KT, Richard J, L'Espérance P, et al. A missed opportunity: a retrospective cohort study of alcohol use disorder pharmacotherapy in hospitalized patients. Alcohol and Alcoholism. 2026. doi:10.1093/alcalc/agag008

BibTeX
@article{Nazon2026,
  author = {Nazon, Michka and Lavin, Paola and Pike, C William and Greenway, Kyle T and Richard, Jérémie and L'Espérance, Paul and Ostacher, Michael and Jutras-Aswad, Didier and Tate, Steven and Lembke, Anna and Garel, Nicolas},
  title = {A missed opportunity: a retrospective cohort study of alcohol use disorder pharmacotherapy in hospitalized patients},
  journal = {Alcohol and Alcoholism},
  year = {2026},
  doi = {10.1093/alcalc/agag008}
}
Kostenlos starten →